1-4 of 4
Joanna Schaenman
Close
Sort by
Journal Articles

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

Clinical Trials & Observations
Sally Arai, Bita Sahaf, Balasubramanian Narasimhan, George L. Chen, Carol D. Jones, Robert Lowsky, Judith A. Shizuru, Laura J. Johnston, Ginna G. Laport, Wen-Kai Weng, Jonathan E. Benjamin, Joanna Schaenman, Janice Brown, Jessica Ramirez, James L. Zehnder, Robert S. Negrin, David B. Miklos
Journal: Blood
Blood (2012) 119 (25): 6145–6154.
https://doi.org/10.1182/blood-2011-12-395970
Published: 2012
Includes: Supplemental data
Journal Articles

Treatment of Severe Acyclovir-Resistant Herpes Simplex Virus Infection with Continuous Infusion of High Dose Acyclovir Following Hematopoietic Cell Transplantation.

Janet H. Kim, MD, Joanna Schaenman, MD, PhD, Dora Y. Ho, MD, PhD, Janice (Wes) M. Brown, MD
Journal: Blood
Blood (2009) 114 (22): 2224.
https://doi.org/10.1182/blood.V114.22.2224.2224
Published: 2009
Journal Articles

Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic Gvhd

Sally Arai, MD, Bita Sahaf, Carol Jones, James Zhender, Robert Lowsky, Samuel Strober, Judith Shizuru, Robert Negrin, Laura Johnston, Ginna Laport, Joanna Schaenman, Janice Brown, Wen-Kai Weng, Renee Letsinger, Ruby Wong, Philip Lavori, David Miklos
Journal: Blood
Blood (2008) 112 (11): 466.
https://doi.org/10.1182/blood.V112.11.466.466
Published: 2008
Journal Articles

Functional Control of CMV Reactivation Is Profoundly Influenced by CMV Serostatus after Nonmyeloablative Hematopoietic Cell Transplantation Following a TLI-ATG Preparative Regimen.

Joanna Schaenman, M.D., Ph.D., Marcy L. Vana, Ph.D., Chanu Rhee, M.D., Jonathan Wong, Shelly Navato, Laura J. Johnston, M.D., Ruby M. Wong, Dora Y. Ho, M.D., Ph.D., Janice (Wes) Brown, M.D.
Journal: Blood
Blood (2008) 112 (11): 2238.
https://doi.org/10.1182/blood.V112.11.2238.2238
Published: 2008